References
- Galan A , Cowper SE , Bucala R. Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy). Curr Opin Rheumatol. 2006 Nov; 18 6: 614– 7.
- Cowper SE. The International Center for Nephrogenic Systemic Fibrosis Research [Internet]. New Haven, CT: Yale Dermatopathology Service; 2013 Jun 15 [cited 2017 Jun 12]. Available from: http://www.icnsfr.org.
- Todd DJ Kay J. Gadolinium-induced fibrosis. Annu Rev Med. 2016; 67: 273– 91.
- Schlaudecker JD Bernheisel CR. Gadolinium-associated nephrogenic systemic fibrosis. Am Fam Physician. 2009 Oct 1; 80 7: 711– 4.
- Perazella MA. Current status of gadolinium toxicity in patients with kidney disease. Clin J Am Soc Nephrol. 2009 Feb; 4 2: 461– 9.
- Vasanwala SS , Nguyen K , Hope MD , Safety and technique of ferumoxytol administration for MRI. Magn Reson Med. 2016 May; 75 5: 2107– 11.
DOI: https://doi.org/10.14797/mdcvj.751 | Journal eISSN: 1947-6108
Language: English
Page range: 172 - 173
Published on: Jul 1, 2017
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
© 2017 Anita H. Shah, Juan Jose Olivero, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.